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T cell repertoire and the presence of opportunistic nfectious post 
transplant. Thymic fimction may be preselwed in patients who 
receive reduced intensity preparative regimens leading to 
enhanced T cell neogenesis following transplant. Alternatively, 
the presence of mixed hematopoietic/13qnphoid chimerism follow- 
ing non-nayeloablative regimens may adversely impact thymic 
function. To examine these alternatives we examined reconstitu- 
tion of TREC in 12 patients who received a NM-HSCT from 
HLA-identical siblings or unrelated onors. The conditioning 
regimen consisted of fludarabine (30 mg/m2/day x 4) and IV 
busulfan (0.8 mg/kg/day x 4). GVHD prophylaxis consisted of 
prednisone and cyclosporine. Only 20% of patients developed 
transient neutropenia (ANC <500/all) following transplant. Mixed 
hematopoietic chimerism was established in all patients. TREC 
were measured by quantitative PCR in genomic DNA extracted 
from PBMC prior to transplant and then at the 1, 3, 6 and 12 
month time points. TREC values decreased by 1.5 logs 1 month 
post transplant and recovered to pre-transplant levels at 3 and 6 
months after transplant. In contrast to recovel T after myeloabla- 
tive regimens, TREC values remained higher after NM-HSCT 
and no patients had undetectable TREC values. These results 
indicate that thymic function is preserved after reduced intensity 
conditioning and that T cell neogenesis remains relatively intact 
following transplant. Further studies will examine the influence of 
chimerism and GVHD on TREC recovery. These observations 
support he hypothesis that T cell function reconstitutes more 
rapidly in patients who receive allogeneic hematopoietic stem cells 
following non-myeloablative conditioning. 
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FUNCTIONAL ANALYSES OF CYTOMEGALOVIRUS-SPECIFIC LONG- 
TERM MEMORY EFFECTOR CELLS 
Kod,~e, G.; T~/ved/, D.; ~V///hm~s, R.K; O'Rdlly, N.J. Al/oge~dc Bo~e 
3/Iavvow T~:a~stdm~tatio~, 3/[emorial Sloa~-k~'tte~'i~g Ca~cev Ce~te~, 
New York, NK 
Expression of CCR7 and CD45RA have recently been used for 
sub-classifications of"memory T cells. CCR7+CD45RA-CD8+ lym~ 
phocytes, central memory cel]s, lacking immediate effector ftmetion, 
develop into CCRT-CD45RA-CD8+ cells upon secondary stinrula- 
tion, termed effector memory cells. Subsequendy, these cells can fur- 
ther develop into a CCR7-CD45RA+ cell subset. I  is speculated that 
these ceils are ten~ainally differentiated, finally u dergoing apoptosis. 
~,'Vhen we analyze cytomegalovin~s (CMV) peptide-specific T cells 
of HLA-A*0201+, seropositive donors, stained and isolated with 
MHC tetranaers complexed withA*0201-restricted NLVPMVATV 
epitope, we demonstrate in 3 CMV+/A*0201+ donors tested that 
>90% of the MHC-tewamer+ T-cell population iscontained within 
the CCRT-CD45RA+ memou-cell subset. All of these cells stained 
positively for intracellular perforin, whereas none of the CCR7 
expressing CD8+ cells stained positive for perforin. We purified the 
CCRT-CD45RA+ memory-cell subset (>95% purity by ilmnunoab- 
sorption) and found that we enriched the NLVPMVATV-peptide 
specific T-cell population by 2-3 fold (up to 12 % ofMHC tetramer+ 
cells) within the isolated cell fraction compared to 1-4% oftetramer+ 
cells within the non-purified CDS+ cell-population. Although the 
isolated CCR7-CD45RA+ contained 12% of NLVPMVATV-epi-  
tope specific T cells and all cells stained positive f r intracellular per- 
forin, these ceils failed to lyse or to produce intracellular IFN-y in 
response to peptide pulsed K562 cells, transduced to xpress A*0201 
(K562/A*0201) or CMV infected MRC-5 fibroblasts. However, 
when these cells were stimulated with NLVPMVATV-pulsed 
monocyte-derived dendritic ells for 10 dayg and re-analyzed, the T 
cells generated were now CCR7-CD45RA-, of which 98% were 
MHC-tetramer+. Furthermore, 89% p'roduced intracellular [FN-y 
in response to stimulation withpeptide pulsed K562/A*0201 and 
11% in response to CMV-infected MRC-5 fibroblasts. These results 
therefore suggest that CCR7-CD45RA+ ceils are not terminally dif- 
ferentiated and can give rise to highly functional effector cells, pro- 
vided these cells are re-activated and converted to CD45RA- effector 
memory cells. Isolation of CCRT-CD45RA+ T-cell populations may 
offer a new approach for the rapid selection and generation ofvirai- 
antigen specific T cells, since multiple epitope-specific T cells may 
be contained within this memory T-cell pool. 
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T CELL FUNCTION AND CYTORINES IN AUTOLOGOUS PBSC 
TRANSPLANTATION: COMPARATIVE ANALYSIS OF IMMUNE CELL 
POPULATIONS WITHIN THE PBSC GRAFT VS BLOOD POST 
TRANSPLANT 
GoldlJla77, F.D.; B,%Ttl~2d, L.; TbompsoJ~, A.; SilveTwla~, 3~I. Umversi- 
t~' o[Iowa Cbihl're11~ Ho~7~iml , Ioz~a d~'O, , L4. 
Prompt imnmne reconstitution has been noted in autologous 
peripheral blood stem cell (PBSC) transplant recipients, perhaps 
related to increased number of T cells and higher cytokine levels 
in the PBSC graft relative to marrow. Currently it is unknown 
whether qualitative and/or quantitative characteristics of the 
PBSC graft influence subsequent imnmne reconstitution post 
transplant. To address this, we analyzed various immune parame- 
ters of the PBSC product and compared this to peripheral blood 
from the same patients early post transplant. Five patients were 
studied within 1-2 months post transplant, having recovered from 
the acute toxicity of the myeloablative therapy. Innnunopheno- 
typing was performed on fresh peripheral blood or thawed cells 
from the PBSC product using a panel of monoclonal ntibodies to 
assess T, B, NK cells, and T cell subsets. T ceil antigen receptor 
(TCR) signaling was assessed by measuring upregulation of sur- 
face activation markers CD69 and CD25 post anti-CD3 stimula- 
tion. Thl and Th2 cytokines were quantitated by real time PCR, 
measuring basal and anti-CD3 stimulated mRNA levels of IL-2, 
IL-4, IL-5 and IFN7. Of note, the PBSC product contained 0-3 % 
B cells, similar to that seen post transplant, W~hile NK ceils 
accounted for 8-I2% of the graft, this was the predominant cell 
type early post transplant. T cells (CD4 and CD8) were the pre- 
dominant cell type in the PBSC graft, accounting for nearly 75% 
of the total lymphocytes. While the CD4:8 ratio and 
CD45RA:RO ratio was shnilar in the pre and post transplant set- 
ting, a relative decrease in T cell numbers was noted post trans- 
plant.TCR-mediated responses (CD25 and CD69 upregulation) 
were intact in the PBSC product, and somewhat decreased in the 
post transplant setting. IFN 7 was markedly elevated in the blood 
post transplant (16 fold increase) relative to levels noted in the 
PBSC graft. Similarly, IL-2 and IL-4 levels were also increased 
(2-4 fold) post transplant. In conclusion, the imnmnophenotype 
of the PBSC graft did not correlate with that noted in the periph- 
eral blood early post transplant. Furthernaore, the finding of umd- 
erately intact TCR-mediated responses and increased Thl  and 
Th2 cytokines uggests that T cells appearing early post PBSC 
transplant are functional and capable of mediating immune 
responses. 
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THE T LYMPHOCYTE RESPONSE TO ASPERGILLUS (ASP) RESULTS IN 
RAPID TNF-cc, IFN-7 AND IL-2 INTRACELLULAR CYTOKINE (ICC) 
PRODUCTION AND CAN OCCUR WITHOUT APCS 
Hearse/, N.; EL Has, rap, I.; Ba~v'ett, ,7, Ste111 Cell A/logelzeic Tl'a1~splal~- 
tatioJ7 SectioJ~, Hell~ntolo©, B1vT~ch, NHLBI, Natio~zLI1 b~stitzttes of" 
Health, DHHS, Bethe.rchT, 3lID. 
\¥e studied T cell responses to aspergillus to develop ossible 
immunotherapy strategies to treat invasive aspergillosis after allo- 
geneic stem cell transplant. T cell responses to Asp were evaluat- 
ed using PBMC obtained by apheresis from healthy volunteers. 
Heat-killed, irradiated, sonicated hyphae and conidia of Aspergillm" 
f'a~1dg~tlls were used as antigens. Intracellular production of IL-2, 
IL-4, IL-5, IL-10, IL-13, TNF-0~ and IFN-¥ by CD4 and IL-2, 
TNF-ct and IFN- 7 by CD8 cells was measured by flow cytome- 
try. Proliferation responses was measured by 5-day tritiated 
thymidiffe incorporation. T cell responses were further character- 
ized using a panel of 21 TCR V~ mouoclonal antibodies. The 
predominant cytoldnes detected after a 6-hour exposure to Asp 
cotiidia aud hyphae were IL-2, IFN-7 and TNF-ct. Normal sub- 
jects were tested by ICC. See TABLE. Proliferation to conidia 
and hyphae was tested in 15 leukapheresis samples. Stimulation 
indices (S]) varied from 2-30 (hyphae) and 3-18 (conidia). TCR
V[} analysis showed expansion in CD4 and CD8 T cells. The V[3 
profile after 5-day stimulation showed preferential expansion of 
V135.2, 11, 13.6 and 23, independent of HLA type. We next 
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examined the role ofAPC (monocytes and B ceils) in presentation 
of Asp to T ceils by comparing proliferative responses of APC- 
depleted and non-depleted samples. Mthough proliferation was 
greater in the presence of APe, depleted samples howed signifi- 
cant proliferation (SI 2-30) indicating that Asp directly stimulates 
T cell proliferation. These results how a moderately strong CD4 
and CD8 T cell response to Asp that shows some TCR V]3 
restriction. The T cell proliferative response to Asp appears to be 
partly mediated by a non-classical APC-independent pathway. 
These findings should facilitate the generation of Asp-specific T
ceils for adoptive immunotherapy. 
% Cytokine Positive Cells (median, range) 
T Ceil Subset Cytokine n= I Hyphae Conidia 
I 
CD8 I IL-2 40 0.37, 0-1 A3 ~ 0X)6.0-2.21 . 
~ NF e* 13 i 0.26, 0-0.8610.03.0-1.13 
CD4 ] IFN y I0 (k O (L63 OJ)4, 0 0.56 
~ F N - T  l0 I 0.01.0-0A9 iJ0.1~t,, 0-(,.39 
I I I 
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THI AND TH2 CYTOKINE SYNTHESES BY T CELLS OF RECIPIENTS OF 
G-CSF MOBILIZED ALLOGENEIC PBSC 
Lee, B.; KovbliJ~g, M.; Gao, H.; S/:e~7, D.; Ma:'tiJze~, 3:1.3/1.; 
C,bamplin, R.; Re~lbe~z, ff.M. M.D.A1zde'~'soH CaT~cer CeJztet', Hoz/s- 
to~, TJC 
Transplantation f G-CSF-mobilized PBSC is associated with 
less acute GVtlD (aGVHD) and improving engraftment despite 
much larger numbers of T ceils in unmanipulated PBSC prepara- 
tions than in bone marrow grafts. As urvival of the graft is depend- 
ent on the Thl /Th2 cytokine balance, we measured the syntheses 
of Th l  (IL-2, TNF-alpha, and IFN-gamma) and Th2 (IL-10) 
cytokines by CD4+ and CDS+ T ceils in vitro following activation 
with phorbol ester (PMA) and Staphylococcus enterotoxin B (SEB) 
at 2, 4, 6, and 8 weeks, post-transplantation andanalyzed the cells 
syuthesizing cytokines by 4-color flow cytomett T. Typically, the 
number of CDS+ T cells that synthesized TNF-alpha, IFN- 
gamma, and IL-2 following activation with PMA and SEB steadily 
increased with engraftment. The number of CD4+ T ceils that 
were activated with PMA also steadily increased with engraftment; 
however, the number of SEB-activated CD4+ T ceils that synthe- 
sized IL-2 peaked at 4 weeks, post-transplantation and declined 
thereafter. By comparison, the number of CD4+ and CD8+ T cells 
that syuthesized IL-10 in response to activation by PMA and SEB 
peaked at 4 weeks and declined precipitously by week 8, post-trans- 
plantation. Since only one patient developed GVHD that resolved 
during the monitoring period, the increased syntheses of Th l  
cytoldnes by activated CD4+ and CD8+ T cells after engraftment 
and at a time when G-CSF maintenance was no longer provided is 
indicative of the immune competence of the engrafted cells and 
their propensity for producing Thl  cytokines upon activation, an 
event hat could potentially lead to the development of GVI ID. 
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RAPID RECONSTITUTION OF SERUM ANTI-PRP ANTIBODY LEVELS IN 
RECIPIENTS OF ALLOGENEIC MARROW TRANSPLANTATION 
Bolotizz, E.; Reiss, U.; I4,~lltevs, M. Chihh'em" Hospital aTzd Research 
CeJm, r at Oak~an& OaklaJld, CA. 
As immediate survival of the transplant recipients improves, pre- 
vention of early and Iate post-transplant infectious c mplications 
plays a major role in long-term outcome. Timely re-immunization 
for pediatric stem cell transplant (HSCT) recipients may prevent 
devastating complications of vaccine-preventable diseases. 
Immune responses to polysaccharide vaccines (H. influcnzae type 
b, pneumococcal nd meningococcal) have been suboptimal early 
post-transplant. Polyribosyl-ribitol phosphate (PRP) is an essen- 
tial componcnt of bacterial capsular polysaccharides, such as of 
Streptococcus pneumoniae or Hemophilus influenzae. Natural 
antibodies to the polysaccharides develop as a result of the anti- 
genic crossreactivity with E.coli strains. To evaluate the time and 
pattern of anti-PRP titers in pediatric patients after allogeneic 
related HSCT 7 patients were evaluated 6-12 months post- BMT. 
Two patients had a history of acute graft versus host disease, how- 
ever all patients were off immunosuppression at the time of evalu- 
ation. Titers were measured by enzyme-linked immunosorbent 
assay (ELISA) at Children's Hospital Los Angeles; CA. Serum 
anti-PRP titers varied from 16 to 900 pg/ml, median 117pg/ml. 
Anti-PRP titers were higher (200-900 pg/ml, mean 900 pg/ml) in 
patients with non-malignant diseases compared to patients with 
malignancies (16-228, mean 48 pg/ml). There were no significant 
correlation with the T and B ceil counts and T cell function. Non- 
protective anti-PRP levels (less than i00 pg/ml) at 1 year after 
I tSCT were observed in two AML patients. In one low anti-PRP 
titers were associated with non-detectable anti-tetanus, anti-diph- 
theria antibody titers and low B cell count. In this study we 
observe rapid reconstitution of the serum anti-PRP titers in 5 of 7 
recipients of allogeneic BMT. Currently we are studying the pre- 
dictability of serum anti-PRP ievels with regard to functional 
responses to vaccination post-BMT. 
135 
ANTI-CD3 STIMULATED T REGULATORY CELLS DO NOT INHIBIT 
SYNGENEIC BONE MARROW PROGENITOR CELL PROLIFERATION 
Dayao, Z.RS; Marl's, L.:; Levy, R. 2 l. Divisio*z of Hematology~ 07zcol- 
og)', Sylvestev Cmzcev Ce*~te~'- U, ziversity of k/liami, Mia71~i, FL; 
2. Uniz,elsi U of dVIiuTni School of Me,ticil~e, Miami, FL. 
CD4+CD25 * T (T reg) cells with regulatory function are being 
considered for use to control GVHD and support successful allo- 
geneic bone marrow transplantation. T reg cells are present in the 
spleen and bone marrow and have been reported to produce 
cytokines including TGF]3. Since encounter with antigen post 
BMT can activate Treg populations, the presence of such ceils in 
recipient lymphohelnatopoietic conapartments raises the possibili- 
ty that TGF{3 or other cytokines could affect progenitor cell activ- 
ity. Low density (LD) B6 bone marrow cells (Sxl03/well) were 
supplemented with rmIL3 to induce proliferative responses in 72 
hour cultures. Highly enriched Treg populations were then pro- 
duced fi'om spleen and lymph nodes of B6 (H-219 mice. When 
added to cultures containing purified syngeneic CD4+CD25 - T 
cells (SxlOVwell), syngeneic accessory cells (Sxl0~/well) and anti- 
CD3 nLAb (15%), the Treg cells (1:1) effectively inhibited (>70%) 
the proliferative response by the CD4+CD25- responding cells. To 
examine the ability, of T reg cells to regnlate BMC proliferation, 
CD4+CD25 + T ceils were cultured with LD BMC and syngeneic 
accessory cells in the presence of anti-CD3 nzAb. At high (10:1) 
Treg : LD BMC numbers, the BMC proliferative responses were 
not inhibited. In summary, the present i71 vitro findings support 
the notion that activation of CD4+CD25 + T reg cells during BMT 
will not interfere with t e proliferative activity of transplanted or
host progenitor populations. Interestingly, when both 
CD4+CD25 T cells and LD BMC were cultured together with 
Treg cells in the presence of IL-3 and anti-CD3, strong prolifera- 
tive responses were detected in these cultures. These findings raise 
the possibility that CD4*CD25 + regulatory cells do not inhibit 
proliferative responses in the presence of IL3 and BMC. Experi- 
ments are currently examining if T reg ceils fail to suppress the 
response of the CD4+CD25 T cells in these cultures. 
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SEX STEROID ABLATION BY CASTRATION ENHANCES HAEMOPOI- 
ETIC RECOVERY FOLLOWING ALLOGENEIC BONE MARROW 
TRANSPLANTATION 
Goldl, erg, G.L.I; Alpcloga1~, 0.:; Mu~'iglm~, S.J.:; 14,7i/lis, L.M.:; 
G*'eeizbeJ'g, A.S.~-; Bwd, R.L2; va~ cle71 Bri71k, M.R. 2 1. Pathology mzd 
I~zTn#~zologv, Mol~asb UMveT"sity, Melboz~twe, VIC, Aztst¢-alia; 
2. 3/le'/Jzo~ial Sloml Ketterhg CaT~ce*" Ce,zter', New Yo*'/e, NI£ 
"['here is a general decline in immune function with age. This 
process, which involves thymic atrophy, is known to be reversed 
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